The role of the lipogenic pathway in the development of hepatic steatosis.
about
Modulation of hepatic steatosis by dietary fatty acidsRegulation of lipogenesis by cyclin-dependent kinase 8-mediated control of SREBP-1Glutathione deficiency down-regulates hepatic lipogenesis in rats.Testosterone replacement ameliorates nonalcoholic fatty liver disease in castrated male ratsC-C chemokine receptor 2 (CCR2) regulates the hepatic recruitment of myeloid cells that promote obesity-induced hepatic steatosis.A maternal "junk food" diet in pregnancy and lactation promotes nonalcoholic Fatty liver disease in rat offspringCrude extracts from Lycium barbarum suppress SREBP-1c expression and prevent diet-induced fatty liver through AMPK activation.The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD).NHE1 deficiency in liver: implications for non-alcoholic fatty liver disease.Exendin-4 Improves Nonalcoholic Fatty Liver Disease by Regulating Glucose Transporter 4 Expression in ob/ob Mice.Chronic ethanol consumption in mice alters hepatocyte lipid droplet propertiesLiver clock protein BMAL1 promotes de novo lipogenesis through insulin-mTORC2-AKT signalingInsulin- and leptin-regulated fatty acid uptake plays a key causal role in hepatic steatosis in mice with intact leptin signaling but not in ob/ob or db/db mice.Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study.DLK1/PREF1 regulates nutrient metabolism and protects from steatosis.Gene expression profile analysis of type 2 diabetic mouse liver.Fatty acid changes help to better understand regression of nonalcoholic fatty liver diseaseEffects of ferulic acid and γ-oryzanol on high-fat and high-fructose diet-induced metabolic syndrome in rats.Aquaglyceroporins serve as metabolic gateways in adiposity and insulin resistance control.Thyroid hormone analogues and derivatives: Actions in fatty liverIncreased hypolipidemic benefits of cis-9, trans-11 conjugated linoleic acid in combination with trans-11 vaccenic acid in a rodent model of the metabolic syndrome, the JCR:LA-cp rat.Vitex agnus-castus L. (Verbenaceae) Improves the Liver Lipid Metabolism and Redox State of Ovariectomized Rats.Gut microbiota and diabetes: from pathogenesis to therapeutic perspective.Ablation of the transcriptional regulator Id1 enhances energy expenditure, increases insulin sensitivity, and protects against age and diet induced insulin resistance, and hepatosteatosis.Red Blood Cell Fatty Acids and Incident Diabetes Mellitus in the Women's Health Initiative Memory StudyMenhaden oil decreases high-fat diet-induced markers of hepatic damage, steatosis, inflammation, and fibrosis in obese Ldlr-/- mice.Deficiency of Interleukin-15 Confers Resistance to Obesity by Diminishing Inflammation and Enhancing the Thermogenic Function of Adipose Tissues.Exendin-4 Inhibits Hepatic Lipogenesis by Increasing β-Catenin SignalingProtective Effects of Alisma orientale Extract against Hepatic Steatosis via Inhibition of Endoplasmic Reticulum Stress.Lack of significant metabolic abnormalities in mice with liver-specific disruption of 11β-hydroxysteroid dehydrogenase type 1.Intestinal GATA4 deficiency protects from diet-induced hepatic steatosisFructus xanthii improves lipid homeostasis in the epididymal adipose tissue of rats fed a high-fat dietA very low carbohydrate ketogenic diet prevents the progression of hepatic steatosis caused by hyperglycemia in a juvenile obese mouse model.Glucose intolerance and lipid metabolic adaptations in response to intrauterine and postnatal calorie restriction in male adult rats.Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis activates Akt signaling to ameliorate hepatic steatosisOleic acid stimulates complete oxidation of fatty acids through protein kinase A-dependent activation of SIRT1-PGC1α complex.Artemisia annua Leaf Extract Attenuates Hepatic Steatosis and Inflammation in High-Fat Diet-Fed Mice.Qushi Huayu Decoction Inhibits Hepatic Lipid Accumulation by Activating AMP-Activated Protein Kinase In Vivo and In Vitro.FT3/FT4 ratio predicts non-alcoholic fatty liver disease independent of metabolic parameters in patients with euthyroidism and hypothyroidism.Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease
P2860
Q26991735-52E3554E-8282-454D-839D-98C1C58D6EFFQ28268591-E1DA7A31-0F5A-4BC7-BFDD-E039B6C43100Q30318687-96A753A0-0602-4CFA-BF53-872149B2A568Q33569603-125FB324-EA00-43E2-A9F5-255520F77218Q33750735-64D7BFC9-A696-4837-8438-D157D9B14C60Q33772350-9E6D2E6F-F416-4423-9879-43A43C5BE9F2Q33809697-2C017621-6639-495C-A694-A8AF4C02E25EQ33864337-C283E529-2C5A-491A-BDAF-985F52DB2BE6Q33954199-0E25C684-136C-4EB4-BE2D-E82F2FB2D684Q34097903-B1B4DF62-9A52-4679-9DB3-DFFFD1C03892Q34152582-66031429-FF8E-4E0F-B90D-1546726C2B06Q34170848-DF9D4887-81D1-419E-8130-149E91C0B078Q34212126-D144EDE6-96F8-4EC6-921D-DB5B2BC3C645Q34334832-0FF8A52F-7EC3-449B-84A7-D0D4E1436DC9Q34526596-D87E4D0D-6164-4B40-BF38-F9B867E93755Q34613248-5E206429-8CC3-49D7-86B0-92A1F8E6B6EDQ34827519-F8263750-DCB2-4F2C-9FC7-DDD6E5F00CF0Q35043473-6165DC19-27A3-4A39-85B9-ADD6F3D76C5AQ35079321-437723DA-2FD4-49B4-9D54-5A5D58B9AFFAQ35132642-994F17DA-FB26-47F1-BA89-AC94B057A38FQ35180157-9C62E9E6-78E0-4BAB-B7F6-CF5DE09D454CQ35543757-AD64D423-7E0A-412C-B5B4-32022E64F0A5Q35573510-B5D72383-8CB4-4A0C-8271-92FB2CD01542Q35647980-71C920DB-2C00-439B-A11A-2E47E3960A4FQ35924961-B75AADD3-5602-4BB6-9DC1-6DBC883CDEFFQ36096333-3E950BFF-9878-49E7-AE94-EA8BFC0BE79DQ36147727-DF93904C-6006-468D-91BF-6331B5EDC5A1Q36209797-B5E47D03-21D4-4527-B848-6C2C957D3ACFQ36324486-868AC107-DA82-4EB0-8264-37DAB0A392A3Q36331122-3C1EF8DF-3D20-4DC8-9108-CDAC2BE3C975Q36336508-DCABA565-D47C-4632-975E-7B6A2BC1D637Q36390364-28FCDA50-1EC5-4272-BB84-D742CCAB9646Q36424947-0B638769-4C04-453C-B883-FC2232B15C85Q36486178-5A64F8F2-B856-460D-8628-4380ECB826FEQ36587510-A96E3E27-5803-49A8-86B0-3D305E053C81Q36666210-626099F5-D5D8-4E0C-BBCA-E542E8FBBC26Q36705993-194A4B24-4E88-4961-A71B-4A650DB93D75Q36734149-0BEEEF52-0FF6-4F4A-9A9C-9E00E7E78B5AQ36779293-E223611A-8370-4493-BEC3-9D7A4610B383Q36818384-1DF3210F-3C2E-4585-86AE-4DEAC0E2F882
P2860
The role of the lipogenic pathway in the development of hepatic steatosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The role of the lipogenic pathway in the development of hepatic steatosis.
@en
The role of the lipogenic pathway in the development of hepatic steatosis.
@nl
type
label
The role of the lipogenic pathway in the development of hepatic steatosis.
@en
The role of the lipogenic pathway in the development of hepatic steatosis.
@nl
prefLabel
The role of the lipogenic pathway in the development of hepatic steatosis.
@en
The role of the lipogenic pathway in the development of hepatic steatosis.
@nl
P1476
The role of the lipogenic pathway in the development of hepatic steatosis
@en
P2093
P304
P356
10.1016/S1262-3636(08)74599-3
P433
P577
2008-12-01T00:00:00Z